Allied Telesis Holdings KK
6835
Bleach
9162
Plaid
4165
AVIX
7836
Chugai Mining
1491
JP Stock MarketDetailed Quotes
2370 Medinet
- 36
- -1-2.70%
20min DelayTrading Feb 17 10:37 JST
9.53BMarket Cap-7.14P/E (Static)
37High36Low143.00KVolume37Open37Pre Close5.26MTurnover5752wk High0.06%Turnover Ratio264.73MShares3452wk Low-5.04EPS TTM8.79BFloat Cap13900Historical HighLossP/E (Static)244.22MShs Float33Historical Low-5.04EPS LYR2.70%Amplitude--Dividend TTM1.83P/B100Lot Size--Div YieldTTM
Medinet News
MEDINET Co., Ltd. Reports Financial Challenges in Q1 2024
Medinet: Summary of financial results for the 1st quarter of the fiscal year ending September 2025 [Japanese GAAP] (unconsolidated)
MDNT Research Memo (8): Under 'VISION2030', the second medium-term management plan is being promoted.
■ Medinet <2370> mid-term management plan 1. Overview of the second mid-term management plan Since April 2022, the management leadership has transitioned from founder Mr. Kimura to Mr. Kuhiro, and they are advancing discussions on a new mid-term management plan that incorporates new perspectives and points of discussion. The company announced "VISION2030," a corporate vision aimed at 2030 (the desired state of the company ten years later), and is utilizing a backcasting approach (a method that traces the path from the future to the present) to develop "VISION203.
MDNT Research Memo (2): A biotech venture in the field of "cancer immune cell therapy." Promoting corporate transformation.
■Company Overview of Medinetwork <2370> 1. History (1) Foundation The company is a pioneer in the field of "cancer immunotherapy" and is a biotech venture. The current Chairman, Mr. Kimura, was responsible for the sales of contact lenses and Medical Devices at Hoya Glass Co., Ltd. (now HOYA <7741>), which led to the founding of the company in 1995 to develop and commercialize cancer immunotherapy. Subsequently, Mr. Kimura has been researching cancer immunotherapy with Dr. Egawa at the University of Tokyo Institute of Medical Science.
Volume change rate ranking (9 AM) - Onward HD, BTM, ETC are ranked.
By comparing the average volume over the last 5 days with the volume on the day of distribution in the Volume Change Rate Ranking, it is possible to understand the trends in buying and the interests of market participants. ■ Top Volume Change Rates [As of January 9, 9:32 AM] (Comparison of the average volume over the last 5 days) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Stock Price Change Rate ＜3656＞KLab 2010300 107185.08 104.51% -0.1785%
Medinet: Extraordinary Report
Volume change rate ranking (10 o'clock) - Okano Ball, Heiwa ETC ranked.
※ The ranking of Volume change rates allows understanding the trends in market participants' interests by comparing the average volume of the last 5 days with the volume on the day of distribution. ■ Top Volume Change Rates [As of December 19, 10:35] (Comparison of the average volume of the last 5 days) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Stock Price Change Rate <6412> Heiwa 1982800302555.64304.63% 0.1512% <2846> NF Da
Medinet: Confirmation
Medinet: Financial Report - 29th Term (2023/10/01 - 2024/09/30)
Ranking of Volume change rate (9 AM) ~ ispace, Yumetembo ETC are ranked.
In the volume change rate ranking, by comparing the average volume over the last five days with the volume on the day of the distribution, it is possible to understand the trends of stock selections and the interests of market participants. ■ Top volume change rates [As of December 18, 9:32] (Comparison of average volume over the last five days) Stock code Stock name Volume Average volume over five days Volume change rate Stock price change rate <3185> Yumetenbou 4795800 107185.08 256.46% 0.3571% <7222> Sangoshatai
Medinet: Financial results briefing materials for the fiscal year ending 2024/9
rakuten group, 3Q operating loss narrowing to ¥51 billion.
The earnings report for the third quarter of the fiscal year ending December 2024, announced by rakuten Group (4755), showed a revenue of 1 trillion 617.6 billion 21 million yen, an increase of 8.5% compared to the same period last year, while the operating loss was 51 billion 66 million yen (compared to a loss of 179.5 billion 78 million yen in the same period last year). Continued losses were burdensome due to upfront investments in the mobile business. The internet sector, including e-commerce (EC), and financial services were robust. [Positive evaluation] (7911) TOPPAN HD Mid-term| (3496) Azoom.
Medinet: Summary of financial results for the fiscal year ending September 2024 [Japanese GAAP] (unconsolidated)
Medinet Co Sees Parent FY Loss Y1.49B
Volume change rate ranking (9:00) - Bandai Namco, Ine, etc. ranked in.
In the volume change rate ranking, you can understand the market participants' interest in trends such as speculation by comparing the average volume for the past 5 days with the volume on the day of delivery. Top volume change rates [As of 9:32 on October 24] (comparison with the average volume for the past 5 days) Stock code Stock name Volume 5-day average volume Volume change rate Stock price change rate ＜4933＞Ine137400107185.08 154.44% 0.11% ＜1514＞Sumiishi
Volume change rate ranking (9:00) - Shima Chemical, Ribomic, etc. are ranked.
*In the volume change rate ranking, you can understand the interest of market participants such as trends in hunting by comparing the average volume of the past 5 days with the volume on the day of delivery.
The TOPIX Growth Market 250 Index fell for the third consecutive day, with the sudden drop in GENDA also affecting investor sentiment negatively.
Tokyo Stock Exchange Growth Market Index 808.04 -23.28 / Volume 0.2 billion 17.54 million shares / Trading value 116.6 billion yen Tokyo Stock Exchange Growth Market 250 Index 632.14 -18.68 / Volume 0.1 billion 57.87 million shares / Trading value 91.8 billion yen The growth market today, both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index fell for the first time in three days. The number of advancing stocks was 81, the number of declining stocks was 480, and unchanged was 21. The US market on the 10th was mixed. The Dow average is 92.63 dollars.
Emerging markets stock digest: Edge Technology significantly extended for the 5th consecutive day, ProdiLight hit the daily limit.
It has hit the daily limit and updated its year-to-date high. It was disclosed on the 9th that it obtained a patent related to technology that can analyze human emotions from voice, and it continues to be seen as a buying factor.
Volume change rate ranking (13:00) - Kaioom, Liberta, etc. are ranked
In the volume change rate ranking, you can know the market participants' interest in trends and other things by comparing the average volume of the past 5 days with the volume on the day of delivery. Top volume change rate [as of September 11, 13:32] (comparison of average volume of the past 5 days) Code ⇒ Stock name ⇒ Volume ⇒ 5-day average volume ⇒ Volume change rate ⇒ Stock price change rate <2370> MDNT 32429100 49370.52 343.59% 0.159% <3903>
MDNT - significant increase, strategic partnership agreement with AGC in the cell therapy drug CDMO business.
AGC <5201> announced that it has entered into a strategic partnership agreement in the cell therapy drug CDMO (contract manufacturing and development of pharmaceuticals and other products) business. The two companies will work on the exchange and development of human resources related to manufacturing and quality, and complement Medinet's development and manufacturing capabilities at AGC's domestic and overseas locations. First, AGC will accumulate knowledge and experience in Japan through Medinet's support, and prepare for the launch of cell therapy drug CDMO services at its Yokohama facility.